You are here » News

News

Entries for 2013

October 31, 2013

Egerkingen, Switzerland – October, 2013 Thanks to the acquisition of Spirig, Galderma is now the leading dermatology company in Switzerland. &...

Read more...

Posted in: News

October 27, 2013

FT. WORTH, Texas – October, 2013 Galderma US has served as the premier sponsor for the 2013 Commit to Cure gala, the National Psoriasis Founda...

Read more...

Posted in: News

October 01, 2013

FT. WORTH, Texas – October, 2013 Cetaphil, the #1 dermatologist-recommended line of cleansers and moisturizers in the U.S. has teamed up with C...

Read more...

Posted in: News

September 11, 2013

Jeannette R. Jakus, MD, MBA, has been selected as the 2013 recipient of the American Academy of Dermatology Translational Biotechnology Fellowship, a partnership of the American Academy of Dermatology and Galderma Research & Development, SNC.

Read more...

Posted in: Press release

August 26, 2013

the First and Only FDA-Approved Topical treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea 
Mirvaso Works Quickly and Lasts for up to 12 Hours2

FT. WORTH, Texas – August 26, 2013 – Galderma Laboratories, L.P. today announced that the U.S. Food and Drug Administration (FDA) has approved Mirvaso® (brimonidine) topical gel, 0.33%* for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older.1 Applied once-daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours.2  Galderma expects Mirvaso to be available in pharmacies September 2013.

Read more...

Posted in: Press release

 1 / 2  

Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world

Read

Video

We are committed

See all videos